Reference health
Low IFN-γ Response after Cell Stimulation Predicts Hospitalization in COVID-19 Patients
27/27 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
15 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 27 checked references that resolve
resolves10.1001/jama.2020.1585
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
resolves10.1183/13993003.00547-2020
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis
resolves10.1016/S0140-6736(20)31142-9
Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis
resolves10.1056/NEJMoa2023184
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
resolves10.1186/s12916-020-01636-4
A prospect on the use of antiviral drugs to control local outbreaks of COVID-19
resolves10.1016/S0140-6736(20)31022-9
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
resolves10.1080/07853890.2022.2034936
Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19：a meta-analysis
resolves10.1016/S0140-6736(20)31042-4
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
resolves10.1016/j.intimp.2020.106903
Interferon β-1b in treatment of severe COVID-19: A randomized clinical trial
resolves10.1016/j.chom.2020.07.005
Retrospective Multicenter Cohort Study Shows Early Interferon Therapy Is Associated with Favorable Clinical Responses in COVID-19 Patients
resolves10.1016/S2213-2600(20)30511-7
Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial
resolves10.1016/j.ijid.2021.03.015
Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study
resolves10.1007/s10875-021-01036-0
Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain
resolves10.1084/jem.20210583
Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics
resolves10.1038/s41467-021-27318-0
Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2
resolves10.3389/fmed.2020.608804
Humoral and Cellular Response of Frontline Health Care Workers Infected by SARS-CoV-2 in Nice, France: A Prospective Single-Center Cohort Study
resolves10.3389/fmed.2020.603961
Functional Exhaustion of Type I and II Interferons Production in Severe COVID-19 Patients
resolves10.1016/S0140-6736(20)30566-3
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
resolves10.1038/s41577-020-0348-8
Considering how biological sex impacts immune responses and COVID-19 outcomes
resolves10.1002/oby.22831
High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) Requiring Invasive Mechanical Ventilation
resolves10.1038/s41590-021-01113-x
Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection
resolves10.1016/j.cca.2019.11.018
Functional immune assay using interferon-gamma could predict infectious events in end-stage kidney disease
The 15 references without a DOI — listed, not checked
no DOI — not checkedGender Differences in Patients With COVID-19: Focus on Severity and Mortality
no DOI — not checkedObesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital Admission
no DOI — not checkedEffectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis
no DOI — not checkedSafety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
no DOI — not checkedref8
no DOI — not checkedInterferon-?2b Treatment for COVID-19
no DOI — not checkedPeginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial
no DOI — not checkedUse of anti-spike monoclonal antibodies in kidney transplant recipients with COVID-19: Efficacy, ethnic and racial disparities
no DOI — not checkedEarly administration of Anti-SARS-CoV-2 Monoclonal Antibodies prevents severe Covid-19 in Kidney Transplant Patients
no DOI — not checkedImpaired type I interferon activity and inflammatory responses in severe COVID-19 patients
no DOI — not checkedAutoantibodies against type I IFNs in patients with life-threatening COVID-19
no DOI — not checkedInborn errors of type I IFN immunity in patients with life-threatening COVID-19
no DOI — not checkedEarly nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs
no DOI — not checkedClinical and immunological features of severe and moderate coronavirus disease 2019
no DOI — not checkedEpidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.2139/ssrn.4095756"><img src="https://citestamp.com/citestamped/10.2139/ssrn.4095756/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.2139/ssrn.4095756)